Investor Confidence Inclines As Astera Labs Inc (NASDAQ: ALAB) Shares Gain $6.86

In the last trading session, 3.69 million Astera Labs Inc (NASDAQ:ALAB) shares changed hands as the company’s beta touched 0.19. With the company’s per share price at $72.18 changed hands at $6.86 or 10.50% during last session, the market valuation stood at $11.70B. ALAB’s last price was a discount, traded about -104.2% off its 52-week high of $147.39. The share price had its 52-week low at $36.22, which suggests the last value was 49.82% up since then. When we look at Astera Labs Inc’s average trading volume, we note the 10-day average is 5.33 million shares, with the 3-month average coming to 5.45 million.

Analysts gave the Astera Labs Inc (ALAB) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.40. If we narrow down to specifics, the data shows that 0 out of 7 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended ALAB as a Hold, 6 felt it is a Buy and 0 rated the stock as Underweight. Astera Labs Inc’s EPS for the current quarter is expected to be 0.28.

Astera Labs Inc (NASDAQ:ALAB) trade information

Instantly ALAB was in green as seen at the end of in last trading. With action 7.86%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -45.50%, with the 5-day performance at 7.86% in the green. However, in the 30-day time frame, Astera Labs Inc (NASDAQ:ALAB) is -17.51% down. Looking at the short shares, we see there were 9.55 million shares sold at short interest cover period of 1.53 days.

The consensus price target for the stock as assigned by Wall Street analysts is 100, meaning bulls need an upside of 27.82% from its current market value. According to analyst projections, ALAB’s forecast low is 74 with 110 as the target high. To hit the forecast high, the stock’s price needs a -52.4% plunge from its current level, while the stock would need to soar -2.52% for it to hit the projected low.

Astera Labs Inc (ALAB) estimates and forecasts

Year-over-year growth is forecast to reach 70.39% up from the last financial year.

Consensus estimates given by 11 financial analysts project the company’s revenue in the current quarter to hit an average of 151.55M. 10 analysts are of the opinion that Astera Labs Inc’s revenue for the current quarter will be 159.53M. The company’s revenue for the corresponding quarters a year ago was 65.26M and 76.85M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 132.23%. The estimates for the next quarter sales put growth at 107.58%.

The 2025 estimates are for Astera Labs Inc earnings to increase by 50.11%, but the outlook for the next 5-year period is at 43.47% per year.

ALAB Dividends

Astera Labs Inc is expected to release its next quarterly earnings report on 2025-Feb-09.

Astera Labs Inc (NASDAQ:ALAB)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 15.86% of Astera Labs Inc shares while 69.14% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 82.18%. There are 69.14% institutions holding the Astera Labs Inc stock share, with INTEL CORP the top institutional holder. As of 2024-06-30, the company held 3.8036% of the shares, roughly 5.9 million ALAB shares worth $357.21 million.

ATREIDES MANAGEMENT, LP holds the second largest percentage of outstanding shares, with 1.7889% or 2.78 million shares worth $168.0 million as of 2024-06-30.

Among Mutual Funds, the top two as of Dec 31, 2024 were Vanguard Total Stock Market Index Fund and Fidelity Growth Company Fund . With 3.73 shares estimated at $269.41 million under it, the former controlled 2.30% of total outstanding shares. On the other hand, Fidelity Growth Company Fund held about 2.06% of the shares, roughly 3.33 shares worth around $240.55 million.